Cite
HARVARD Citation
Ito, T. et al. (2022). Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2‐week‐on and 1‐week‐off schedule. Journal of clinical pharmacy and therapeutics. pp. 81-88. [Online].